The Rottenstein Law Group, which represents clients with claims stemming from the failures of defective hip replacement devices manufactured and sold by various companies—including Stryker Corp—is encouraged by the recent Reuters report about a recommendation of the company that all recipients of its recalled Rejuvenate and ABG II devices see a doctor, even if no symptoms of harm are present.
(PRWEB) January 11, 2013
The Rottenstein Law Group is encouraged by hip replacement system maker Stryker's recommendation this week that all recipients of its recalled Rejuvenate and ABG II devices see a doctor, even if no symptoms of harm are present.
According to a Wednesday Reuters report, Stryker Corp has announced that the recall of two of the company’s hip implant device that began last June “will cost $190 million to $390 million for patient testing and treatment, new surgeries, lawsuits and insurance payments.”
Read full story at PRWeb: Rottenstein Law Group Encouraged by Recommendation for Hip Replacement Recipients to Visit Doctors Amid Report of $390 Million Stryker Hip Recall Cost Estimate
